首页> 外文OA文献 >Metabolic Alterations Associated with Atorvastatin/Fenofibric Acid Combination in Patients with Atherogenic Dyslipidaemia: A Randomized Trial for Comparison with Escalated-Dose Atorvastatin

【2h】

Metabolic Alterations Associated with Atorvastatin/Fenofibric Acid Combination in Patients with Atherogenic Dyslipidaemia: A Randomized Trial for Comparison with Escalated-Dose Atorvastatin

机译：患有血管生殖血脂血症患者的阿托伐他汀/芬纤维酸组合相关的代谢改变：随机试验，用于与升级剂量毒素相比

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ji Soo Han; Kyu Kim; Youngae Jung; Jae-Hwan Lee; June Namgung; Hae-Young Lee; Jon Suh; Geum-Sook Hwang; Sang-Hak Lee;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Metabolic Alterations Associated with Atorvastatin/Fenofibric Acid Combination in Patients with Atherogenic Dyslipidaemia: A Randomized Trial for Comparison with Escalated-Dose Atorvastatin [J] . Ji Soo Han, Kyu Kim, Youngae Jung, Scientific reports. . 2018,第1期

机译：代谢改变与阿托伐他汀/非纤维酸联合治疗致动脉粥样硬化性血脂异常的患者：一项与增加剂量的阿托伐他汀比较的随机试验
2. Comparative study of efficacy and safety of omega 3 fatty acids and fenofibrate with background atorvastatin therapy in patients of atherogenic dyslipidaemia [J] . Ankit Arora, Navyug Raj Singh, Rajiv Sharma International Journal of Basic & Clinical Pharmacology . 2019,第6期

机译：欧米加3脂肪酸和非诺贝特与背景阿托伐他汀治疗动脉粥样硬化性血脂异常的疗效和安全性比较研究
3. Efficacy and safety of fixed dose combination of atorvastatin and hydroxychloroquine: a randomized, double-blind comparison with atorvastatin alone among Indian patients with dyslipidemia [J] . Pareek Anil, Chandurkar Nitin, Thulaseedharan N. K., Current medical research and opinion . 2015,第11期

机译：阿托伐他汀和羟氯喹固定剂量联合用药的疗效和安全性：印度血脂异常患者与单独使用阿托伐他汀的随机，双盲比较
4. Disability Prevention of Metabolic Syndrome: Effects of a Combination Therapy of Exercise Training and Atorvastatin on Plasma Glucose and Adipocytokines in Zucker Fatty Rats [C] . L. Tan, O. Ito, K. Niu, International Society of Physical and Rehabilitation Medicine . 2007

机译：代谢综合征的残疾预防：运动训练组合治疗和阿托伐他汀对Zucker脂肪大鼠血浆葡萄糖和脂肪细胞的影响
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. Metabolic Alterations Associated with Atorvastatin/Fenofibric Acid Combination in Patients with Atherogenic Dyslipidaemia: A Randomized Trial for Comparison with Escalated-Dose Atorvastatin [O] . Ji Soo Han, Kyu Kim, Youngae Jung, -1

机译：代谢改变与阿托伐他汀/非诺贝特酸联合在无源性血脂异常患者中的应用：阿托伐他汀与递增剂量阿托伐他汀比较的随机试验
7. Comparative study of efficacy and safety of omega 3 fatty acids and fenofibrate with background atorvastatin therapy in patients of atherogenic dyslipidaemia [O] . Ankit Arora, Navyug Raj Singh, Rajiv Sharma 2019

机译：ω3脂肪酸和泛料纤维蛋白与血管生殖血脂患者背景阿托伐他汀治疗的疗效和安全性比较研究

Metabolic Alterations Associated with Atorvastatin/Fenofibric Acid Combination in Patients with Atherogenic Dyslipidaemia: A Randomized Trial for Comparison with Escalated-Dose Atorvastatin

著录项

引文网络

相似文献

相关主题

期刊订阅